tadalafil Cialis brand
Selected indexed studies
- Tadalafil. (, 2012) [PMID:31643246]
- A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States. (Urology, 2024) [PMID:37951363]
- ATR-FTIR characterization of generic brand-named and counterfeit sildenafil- and tadalafil-based tablets found on the Brazilian market. (Sci Justice, 2017) [PMID:28606335]
_Worker-drafted node — pending editorial review._
Connections
tadalafil Cialis brand is a side effect of
Sources
- Accurate and sensitive determination of sildenafil, tadalafil, vardenafil, and avanafil in illicit erectile dysfunction medications and human urine by LC with quadrupole-TOF-MS/MS and their behaviors in simulated gastric conditions. (2019) pubmed
- Erectile dysfunction treatment with Phosphodiesterase-5 Inhibitors: Google trends analysis of last 10 years and COVID-19 pandemic. (2021) pubmed
- Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties. (2013) pubmed
- A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States. (2024) pubmed
- ATR-FTIR characterization of generic brand-named and counterfeit sildenafil- and tadalafil-based tablets found on the Brazilian market. (2017) pubmed
- Tadalafil. (2012) pubmed
- Pharmaceutical equivalency of locally and regionally manufactured generic pharmaceutical products in UAE. (2022) pubmed
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test. (2024) pubmed
- Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression. (2010) pubmed
- Importation of prescription medicines into New Zealand: a snapshot of intercepted products. (2011) pubmed